Biomedical research has generated increasingly large, rich, and multidimensional datasets, yet we still often study disease by dividing people into discrete categories: healthy or diseased, responder or non-responder, case or control. Biology, however, does not operate in static states. Disease develops along a continuum, shaped by changing regulatory programs and influenced by aging, biological sex, genetics, epigenetics, and environmental exposures.
As our data and computational capabilities advance, an important opportunity is emerging: moving beyond cataloging molecular differences to reconstructing how biological systems change over time. Gene regulatory networks, pseudo-time modeling, and change-point analysis can help identify critical regulatory switches that move a biological system from one state to another and reveal drivers of disease that may be missed when we focus only on individual mutations, genes, or biomarkers.
These approaches are beginning to provide insight into why individuals exposed to similar risks can follow very different disease trajectories, why biological sex can influence disease susceptibility and treatment response, and how aging may reshape the path toward chronic disease. Identifying these transition points may also uncover new therapeutic targets and opportunities to intervene before disease becomes firmly established.
The ultimate vision is a predictive theoretical biology: The ability to understand where an individual is biologically, anticipate where that trajectory may lead, and identify opportunities to redirect it. Moving from describing disease after it occurs toward predicting and ultimately altering its course could transform how we approach target discovery, therapeutic development, and precision medicine.